Influence of treatment and tumor grade on the prognosis of stage II carcinoma of the endometrium. 1982

T Prempree, and V Patanaphan, and O M Salazar

A retrospective analysis of 53 patients with stage II endometrial carcinoma treated between 1963 and 1975 was undertaken to evaluate the efficacy of treatment methods and the effect of tumor grade on survival and failure. Thirty-eight patients were irradiated preoperatively followed by total abdominal hysterectomy and bilateral salpingo-oophorectomy, 15 were followed for at least 5 years with no lost to follow-up. An overall 5-year disease-free survival of 60.6 per cent was obtained. Further analysis of the data showed that tumor grade and treatment method were important factors influencing the prognosis. The data support the improved survival rate when irradiation is followed by hysterectomy. Patients with a low grade tumor (G1) given preoperative irradiation have a better survival than those with high grade tumor (G3) treated by the same method. Failure rate is also dependent on method of treatment and tumor grade. The results are in agreement with several data in the literature that combination of the irradiation and surgery should be the treatment of choice for stage II endometrial carcinoma. Tumor grade is also an important factor and must be evaluated for the extension of the disease before the proper management. For the high grade tumor, para-aortic node sampling might be important for the irradiation and should warrant further investigation.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

T Prempree, and V Patanaphan, and O M Salazar
March 1978, Cancer,
T Prempree, and V Patanaphan, and O M Salazar
December 2004, Gynecologic oncology,
T Prempree, and V Patanaphan, and O M Salazar
October 1980, Arizona medicine,
T Prempree, and V Patanaphan, and O M Salazar
March 1979, International journal of radiation oncology, biology, physics,
T Prempree, and V Patanaphan, and O M Salazar
July 1978, Obstetrics and gynecology,
T Prempree, and V Patanaphan, and O M Salazar
March 1980, Cancer,
T Prempree, and V Patanaphan, and O M Salazar
September 1978, Cancer,
T Prempree, and V Patanaphan, and O M Salazar
January 1986, European urology,
T Prempree, and V Patanaphan, and O M Salazar
March 1989, Cancer,
Copied contents to your clipboard!